Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Molecular and Cellular Cardiology|April 8, 2006
Modulation of action potential duration on myocyte hypertrophic pathwaysDjamel Lebeche, Roger Kaprielian, Roger Hajjar
Basic Research in Cardiology|December 14, 2002
Targeting Ca2+ cycling proteins and the action potential in heart failure by gene transferRoger Kaprielian, Federica del Monte, Roger J Hajjar
American Journal of Physiology. Heart and Circulatory Physiology|August 16, 2002
Myocardial infarction in rat eliminates regional heterogeneity of AP profiles, I(to) K(+) currents, and [Ca(2+)](i) transientsRoger Kaprielian, Rajan Sah, Tin Nguyen, et al.
Journal of Molecular and Cellular Cardiology|January 7, 2010
KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signalingHongwei Jin, Lahouaria Hadri, Julieta Palomeque, et al.
Circulation|November 24, 2004
In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosisDjamel Lebeche, Roger Kaprielian, Federica del Monte, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 27, 2025
Cost-Effectiveness Analysis of Efgartigimod vs Chronic Immunoglobulin for the Treatment of Myasthenia Gravis in CanadaZaeem A Siddiqi, Cynthia Z Qi, Allen Zhou, et al.
Journal of Health Economics and Outcomes Research|March 16, 2026
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia GravisAna Teresa Paquete, Mark P Connolly, Cynthia Qi, et al.
Canadian Journal of Kidney Health and Disease|February 13, 2020
Clinical Characteristics and Outcome of Canadian Patients Diagnosed With Atypical Hemolytic Uremic SyndromeAnne-Laure Lapeyraque, Martin Bitzan, Imad Al-Dakkak, et al.
Pageof 1